NCT02370784View on ClinicalTrials.gov

Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 15, 2018

Study Completion Date

December 15, 2019

Conditions
Scleroderma
Interventions
DRUG

atorvastatin

Atorvastatin is an oral cholesterol-lowering medication commonly referred to as statin therapy.

DRUG

Placebo

oral drug of similar appearance to atorvastatin

Trial Locations (1)

15261

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Robyn T. Domsic, MD, MPH

OTHER

NCT02370784 - Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma | Biotech Hunter | Biotech Hunter